NCT03285815

Prostate Cancer - Localized Adenocarcinoma Proton Therapy

A Phase II Randomized Trial of Hypofractionated Proton Therapy in Patients With a Localized Prostate Adenocarcinoma

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 156 (estimated)
• Sponsor: National Cancer Center, Korea · Other Government
• Sex: Male
• Age: —
• Healthy volunteers: Not accepted

Summary

A Phase II Randomized Trial of Hypofractionated Proton Therapy in Patients With A Localized Prostate Adenocarcinoma

Detailed description

For Proton therapy with prostate adenocarcinoma patients. Arm 1: Proton therapy 3CGE x 20days = Total 60 CGE for 4 weeks. Arm 2: Proton therapy 4.7CGE x 10days = Total 47 CGE for 2 weeks.

Conditions

• Prostate Adenocarcinoma

Interventions

Type	Name	Description
DEVICE	Proton Therapy

Timeline

• Start date: 2016-05-01
• Primary completion: 2024-05-01
• Completion: 2025-12-01
• First posted: 2017-09-18
• Last updated: 2017-09-18

Locations

1 site across 1 country: South Korea